COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy

Background: Little is known about the 2019 novel coronavirus disease (COVID-19) course and outcomes in patients receiving immunotherapy. Here we describe a metastatic Merkel cell carcinoma patient with a severe acute respiratory syndrome coronavirus 2 infection while receiving pembrolizumab. Case pr...

Descripción completa

Detalles Bibliográficos
Autores principales: da Costa, Cesar Martins, de Souza, Zenaide Silva, Real Salgues, Alessandra Corte, Harada, Guilherme, Marino Rodrigues Ayres, Pedro Paulo, Vieira Nunes, Daniela Bulhões, Katz, Artur, Munhoz, Rodrigo Ramella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480322/
https://www.ncbi.nlm.nih.gov/pubmed/32900245
http://dx.doi.org/10.2217/imt-2020-0193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480322/
https://www.ncbi.nlm.nih.gov/pubmed/32900245
http://dx.doi.org/10.2217/imt-2020-0193

Ejemplares similares